【制药网 医药股市】在2025年港股市场的结构性行情中,医药板块正以强劲的复苏态势成为市场焦点。10月22日,港股医药板块再现异动拉升,多只个股走出亮眼行情。其中,药捷安康-B的表现尤为突出,早盘股价一度飙升超过25%,高见217港元,截至当日10:28,涨幅仍维持在14%以上,报199.20港元,成交额达7.86亿港元,成为板块上涨的核心驱动力。与此同时,盛禾生物-B、贝康医疗-B等个股也纷纷跟...
Source Link【制药网 医药股市】在2025年港股市场的结构性行情中,医药板块正以强劲的复苏态势成为市场焦点。10月22日,港股医药板块再现异动拉升,多只个股走出亮眼行情。其中,药捷安康-B的表现尤为突出,早盘股价一度飙升超过25%,高见217港元,截至当日10:28,涨幅仍维持在14%以上,报199.20港元,成交额达7.86亿港元,成为板块上涨的核心驱动力。与此同时,盛禾生物-B、贝康医疗-B等个股也纷纷跟...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.